Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2026-03-03 @ 2:17 PM
Study NCT ID:
NCT02530320
Status:
COMPLETED
Last Update Posted:
2024-11-22
First Post:
2015-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved
Sponsor:
Grupo Español de Investigación en Neurooncología
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-25
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-18
First Submit QC Date:
None
Study First Post Date:
2015-08-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-02-08
Results First Submit QC Date:
None
Results First Post Date:
2024-11-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-02
Last Update Post Date:
2024-11-22
Last Update Post Date Type:
ACTUAL